GLASGOW, Scotland — New data from a large international registry of thrombolysis in stroke suggest that tissue plasminogen activator (tPA, alteplase) is safe to use in patients with very severe ...

Although the goal for NIHSS completion rate was not met, we believe the project was successful. The NIHSS has been integrated successfully into standard nursing practice in assessments of acute stroke ...

In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone ...

Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.